Clorox (NYSE:CLX) Price Target Lowered to $139.00 at Evercore ISI

Clorox (NYSE:CLX - Get Free Report) had its price target reduced by analysts at Evercore ISI from $140.00 to $139.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an "underperform" rating on the stock. Evercore ISI's price objective indicates a potential downside of 13.98% from the company's previous close.

CLX has been the topic of several other research reports. Barclays boosted their target price on Clorox from $130.00 to $137.00 and gave the company an "underweight" rating in a research report on Friday. TD Cowen initiated coverage on Clorox in a research report on Tuesday, July 23rd. They set a "sell" rating and a $122.00 price target on the stock. Deutsche Bank Aktiengesellschaft increased their price target on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Citigroup upped their price objective on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research note on Friday. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $150.14.

Clorox Stock Up 0.8 %

Clorox stock traded up $1.29 on Monday, hitting $161.59. 991,415 shares of the stock traded hands, compared to its average volume of 1,239,617. The business's fifty day simple moving average is $157.36 and its 200 day simple moving average is $144.72. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The firm has a market cap of $20.07 billion, a P/E ratio of 83.68, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. Clorox has a 1 year low of $114.68 and a 1 year high of $169.09.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, sell-side analysts forecast that Clorox will post 6.64 earnings per share for the current year.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company's stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.51% of the stock is owned by company insiders.

Institutional Trading of Clorox

A number of hedge funds and other institutional investors have recently made changes to their positions in CLX. Innealta Capital LLC purchased a new position in shares of Clorox in the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC lifted its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares during the last quarter. GoalVest Advisory LLC acquired a new position in Clorox during the 1st quarter valued at $31,000. First Foundation Advisors acquired a new position in Clorox during the 1st quarter valued at $31,000. Finally, Family Firm Inc. acquired a new position in Clorox during the 2nd quarter valued at $31,000. 78.53% of the stock is currently owned by institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.